Findings from a study commissioned by the task force prompted the recommendation and revealed “indirect evidence of the benefit of screening for anxiety disorders in adults younger than 65 years and perinatal persons,” according to the update.
“Anxiety disorders are often unrecognized in primary care settings and years-long delays in treatment initiation occur,” the group wrote of its decision. Urging physicians to begin incorporating this into their practice and general patient check-ups could identify disorders sooner, which is the goal.
However, the Task Force also noted that further research is still needed to understand the scope of benefits and effectiveness of anxiety screenings and treatment in older adults.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
